| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.4M | — | +656.6% |
| Cost of Revenue | $442K | — | -43.7% |
| Gross Profit | $1.5M | — | +2689.1% |
| R&D Expense | $12K | — | -24.2% |
| SG&A Expense | $951K | — | +27.6% |
| Operating Income | $554K | — | +177.3% |
| Interest Expense | $49K | — | +118.3% |
| Pre-tax Income | $503K | — | +168.0% |
| Net Income | $312K | — | +139.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $1.4M | +561.9% | +3650.7% |
| Inventory | $610K | -17.4% | -38.4% |
| Current Assets | $11.6M | +140.9% | +43.7% |
| Total Assets | $16.9M | +65.3% | -35.4% |
| Current Liabilities | $16.5M | +38.7% | +11.7% |
| Total Liabilities | $18.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $4.6M | — | +1421.2% |
| Investing Cash Flow | -$14K | — | -475.2% |
| Financing Cash Flow | $771K | — | -40.5% |
| +22.2% |
| Stockholders' Equity | -$1.6M | +24.1% | -115.0% |